Search Results - xiulei+mo

2 Results Sort By:
HTiP: High-Throughput Immunomodulator Phenotypic Screening Platform
­ Application High Throughput Screening for identifying effective immuno-modulators. Key Benefits HT screening platform replicating complex immune medicated response to facilitate discovery of small molecule immunomodulatory agents. Simplicity and dual readouts of the design enable the screening of large chemical libraries to identify compounds...
Published: 11/20/2024   |   Inventor(s): Xiulei Mo, Haian Fu
Keywords(s): Assay, Immunology/Inflammation, Oncology
Category(s): TechPub Algolia > Drug Discovery, TechPub Algolia > Research Tools
KRAS Mutant Protein-Protein Interaction Targets and Inhibitors for Cancer Therapy
Application Immunotherapeutic agent and biosensor for KRASG12V mutation in tumor cells. Key Benefits First in class, targeted immunotherapy for patients presented with KRASG12V mutation. Attenuates immune suppression associated with KRASG12V-positive cancers. Market Summary The KRASG12V mutation, representing 85% of all cancer mutations, is...
Published: 11/20/2024   |   Inventor(s): Haian Fu, Cong Tang, Xiulei Mo
Keywords(s): Enzyme/Protein, Immunology/Inflammation, Oncology, Target
Category(s): TechPub Algolia > Drug Discovery, TechPub Algolia > Therapeutics